| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q1'26 | $1.06 | - | - |
| Q1'25 | $0.94 | $0.97 | +3.3% |
| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q1'26 | $1.1B | - | - |
| Q1'25 | - | $1.0B | - |
Market Data
ILMN is currently trading at $140.51, giving ILMN a market cap of 17.85B and a P/E ratio of 21.0. Today's range spans $114.94–$117.47, with shares opening at $115.19 and moving up $0.26 (0.2%) from the prior close. DailyIQ's technical score sits at 32/100 (SELL) with a news sentiment reading of 55/100.
Over the past year ILMN has traded between $68.70 and $155.53 - the current price is +104.5% off the 52-week low and -9.7% from the high.
ILMN is showing a SELL signal (32/100) with neutral sentiment (55/100). Price: $140.51 (in the upper portion of its 52-week range within $68.70–$155.53). (P/E: 21.0) At 17.85B in Healthcare market cap, a bearish technical read accompanied by negative sentiment often marks the beginning of an earnings revision cycle downward - active managers trim before the revisions become consensus, compounding the selling pressure.
When a large-cap Healthcare name with 17.85B in capitalization prints a SELL signal (32/100) alongside neutral news sentiment (55/100), the risk isn't just price depreciation — it's the loss of institutional sponsorship that makes recovery harder. At $140.51 (in the upper portion of its 52-week range in the $68.70–$155.53 range), the structural support levels are where that sponsorship question gets answered.
Most recent articles, ranked by recency (click to expand).
Sentiment gathered from recent headlines